News Archives - IFF N&H Norway AS https://novamatrix.biz/news/ Wed, 07 May 2025 08:24:57 +0000 en-US hourly 1 https://novamatrix.biz/wp-content/uploads/2025/05/cropped-roquette-corporate-roquette_white-2020-01-529-32x32.png News Archives - IFF N&H Norway AS https://novamatrix.biz/news/ 32 32 Roquette Completes the Acquisition of IFF Pharma Solutions https://novamatrix.biz/roquette-completes-the-acquisition-of-iff-pharma-solutions/ Wed, 07 May 2025 08:14:54 +0000 https://novamatrix.biz/?p=25866 Lille, May 1, 2025 – Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces the successful completion of its acquisition of IFF Pharma Solutions. This strategic milestone marks a significant step forward in its ambition to become a leader in support of the global pharma markets. https://www.roquette.com/media-center/press-center/roquette-completes-acquisition-iff-pharma-solutions

The post Roquette Completes the Acquisition of IFF Pharma Solutions appeared first on IFF N&H Norway AS.

]]>

Lille, May 1, 2025 – Roquette, a global leader in plant-based ingredients and pharmaceutical excipients for the health and nutrition sectors, announces the successful completion of its acquisition of IFF Pharma Solutions. This strategic milestone marks a significant step forward in its ambition to become a leader in support of the global pharma markets.

https://www.roquette.com/media-center/press-center/roquette-completes-acquisition-iff-pharma-solutions

The post Roquette Completes the Acquisition of IFF Pharma Solutions appeared first on IFF N&H Norway AS.

]]> A Life Science Webinar https://novamatrix.biz/a-life-science-webinar/ Fri, 14 Apr 2023 10:55:45 +0000 https://novamatrix.biz/?p=25170 Ultrapure Alginates: Properties and Applications in the Biomedical Field Tuesday, May 09, 2023 4:00 PM Central European Summer Time 1 hour Summary Detailed description: Alginate is a natural polysaccharide extracted from brown seaweed. Its non-animal sourcing, biocompatibility, and availability in ultrapure form make it ideal for biomedical applications. Alginate can be crosslinked with divalent ions to produce hydrogels with tunable mechanical properties. It is composed of 1,4 linked β-D-mannuronate (M) and α-L-guluronate (G) – monomers that control its gelling behavior This presentation will first provide an overview of ultrapure alginates produced by IFF NovaMatrix®. It will highlight the unique molecular properties of alginates including options to functionalize and create various gel morphologies. We will discuss specific studies showcasing the potential uses of alginates and their hydrogels in key biomedical applications, specifically cell-based immunotherapy and 3D bioprinting. Key takeaways: Alginates’ fundamental properties and tunable gelation behavior. Potential modifications to alginates and how functionalization expands their areas of use. Recent literature data showing use of alginates in cell-based immunotherapy and 3D bioprinting. Speakers Dr. Marizela Delic-SchlumbohmAssociate R&D Manager, IFF Pharma Solutions Dr. Marizela Delic-Schlumbohm is Associate R&D Manager for IFF’s Pharma Biotechnology platform (heritage DuPont Pharma Solutions). She is part of the […]

The post A Life Science Webinar appeared first on IFF N&H Norway AS.

]]>
  • Ultrapure Alginates: Properties and Applications in the Biomedical Field
  • Tuesday, May 09, 2023
  • 4:00 PM Central European Summer Time
  • 1 hour

Summary

Detailed description:

Alginate is a natural polysaccharide extracted from brown seaweed. Its non-animal sourcing, biocompatibility, and availability in ultrapure form make it ideal for biomedical applications. Alginate can be crosslinked with divalent ions to produce hydrogels with tunable mechanical properties. It is composed of 1,4 linked β-D-mannuronate (M) and α-L-guluronate (G) – monomers that control its gelling behavior

This presentation will first provide an overview of ultrapure alginates produced by IFF NovaMatrix®. It will highlight the unique molecular properties of alginates including options to functionalize and create various gel morphologies. We will discuss specific studies showcasing the potential uses of alginates and their hydrogels in key biomedical applications, specifically cell-based immunotherapy and 3D bioprinting.

Key takeaways:

  • Alginates’ fundamental properties and tunable gelation behavior.
  • Potential modifications to alginates and how functionalization expands their areas of use.
  • Recent literature data showing use of alginates in cell-based immunotherapy and 3D bioprinting.

Speakers

Speaker 100x100 px

Dr. Marizela Delic-Schlumbohm
Associate R&D Manager, IFF Pharma Solutions

Dr. Marizela Delic-Schlumbohm is Associate R&D Manager for IFF’s Pharma Biotechnology platform (heritage DuPont Pharma Solutions). She is part of the Polymer Synthesis & Modification team located in Bomlitz (Germany), where she leads two laboratories. Marizela additional responsibility is the global technical support for the NovaMatrix® platform. Her role is to closely connect biotech customers’ technology needs with IFF’s R&D and manufacturing capabilities, as well as promoting and incubating additional opportunities in this space. Marizela holds a Master of Science degree in chemistry from the University of Technology in Vienna (TU Wien), and a PhD in Biotechnology (University of Natural Resources and Life Sciences Vienna, BOKU Wien).

Speaker 100x100 px

Dr. Joshua Katz
Senior R&D Manager, IFF Pharma Solutions

Joshua S. Katz is Senior R&D Manager with IFF Pharma Solutions. He received his S.B. in Chemistry with a minor in Biomedical Engineering from the Massachusetts Institute of Technology in 2006. At MIT, he worked under the guidance of Prof. Darrell Irvine. From MIT he moved to the Department of Bioengineering at the University of Pennsylvania, studying under of Professors Jason Burdick and Daniel Hammer, and earning his PhD in 2011. After completing his PhD, he joined the Formulation Science group at Dow Chemical, where he worked on projects focused on encapsulation and controlled delivery for a variety of industries including pharmaceuticals, coatings, agriculture, and industrial composites. As part of the DowDuPont merger and subsequent split, Josh joined the Pharma Solutions business, leading the Colloids and Biopharma R&D group within DuPont Nutrition and Biosciences. In early 2021, DuPont Nutrition and Biosciences merged with IFF, leading to his present position. His research today focuses on fundamentals and applications of biopharmaceutical production and formulation.

Josh has won several awards recognizing his research accomplishments including a Graduate Research Fellowship from the National Science Foundation (2006), Best Poster in Competition from the MIT Biomedical Engineering Society (2006), and a named finalist for the DSM Polymer Technology Award 2011 presented in partnership with the POLY division of the American Chemical Society. He holds 4 US patents, is an author of 7 patent applications, and has over 30 peer-reviewed publications.

Subscribe to the event

The post A Life Science Webinar appeared first on IFF N&H Norway AS.

]]> DuPont Nutrition & Biosciences merged with IFF https://novamatrix.biz/dupont-nutrition-biosciences-merged-with-iff/ Thu, 09 Feb 2023 09:56:31 +0000 https://novamatrix.biz/?p=24874 On February 1st, 2021, DuPont Nutrition & Biosciences merged with IFF (International Flavors & Fragrances) pursuant to a Reverse Morris Trust transaction. As a consequence, NovaMatrix® is now part of the IFF umbrella. IFF is a global leader in high-value ingredients and solutions for the Food & Beverage, Home & Personal Care and Health & Wellness markets. Our NovaMatrix® team still consists of the same, highly qualified team, dedicated to purity, quality, and customer service for our partners in the biomedical, medical device and regenerative medicine industries. Read more: Press Release – Investor Relations IFF – N&B merger

The post <em>DuPont Nutrition & Biosciences merged with IFF</em> appeared first on IFF N&H Norway AS.

]]> On February 1st, 2021, DuPont Nutrition & Biosciences merged with IFF (International Flavors & Fragrances) pursuant to a Reverse Morris Trust transaction. As a consequence, NovaMatrix® is now part of the IFF umbrella. IFF is a global leader in high-value ingredients and solutions for the Food & Beverage, Home & Personal Care and Health & Wellness markets. Our NovaMatrix® team still consists of the same, highly qualified team, dedicated to purity, quality, and customer service for our partners in the biomedical, medical device and regenerative medicine industries.

Read more: Press Release – Investor Relations IFF – N&B merger

The post <em>DuPont Nutrition & Biosciences merged with IFF</em> appeared first on IFF N&H Norway AS.

]]>